BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 26, 2012
View Archived Issues
Leo Pharma prepares novel CaS receptor agonists
Read More
New lysophospholipid receptor modulators designed by Allergan
Read More
New safety data from SMART trials disclosed at ongoing conference
Read More
First clinical data reported on new whole-cell cancer vaccine
Read More
Significance of LMTK3 SNP explored in Japanese patients with gastric adenocarcinoma
Read More
Exelixis presents novel protein kinase inhibitors
Read More
Astex Pharmaceuticals patents new FGFR inhibitors
Read More
Novel FFA1 receptor agonists disclosed by Boehringer Ingelheim
Read More
Amgen divulges new agents for cognition disorders
Read More
Extended-release tablet has encouraging effects in patients with depression
Read More
Ablynx reports on phase II extension study of ozoralizumab
Read More
Lexicon discloses phase IIb data on LX-4211
Read More
MAP Pharmaceuticals updates on Levadex NDA
Read More
FDA issues complete response letter for Eliquis NDA
Read More
Peregrine completes recruitment in bavituximab trial
Read More
Milestone achieved in phase IIb tamibarotene study
Read More
New phase IIb study investigates RP-103 for NASH
Read More
CHMP recommends approval of Afinitor for new indication
Read More
Baxter immunoglobulin is the first to be approved in U.S. for MMN
Read More
Phase III iferanserin study does not meet endpoints
Read More
Neuralstem provides update on phase I trial in major depressive disorder
Read More
Novel candidate therapies for schizophrenia developed
Read More
European CHMP issues opinion on Humira for severe axial spondyloarthritis
Read More
Chugai files for Japanese approval of EGFR inhibitor as first-line therapy for NSCLC
Read More
Ongoing phase III rifampicin trial evaluates safety and efficacy in MSA
Read More
Rienso obtains E.U. approval
Read More